The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Gianluca Pettiti, Executive Vice President of Thermo Fisher Scientific Inc.'s (TMO) Life Sciences Solutions branch, sold 400 shares of the company's stock on February 9, 2026. This transaction continues a pattern of insider selling by Pettiti, who has divested a total of 4,875 shares over the past year without any corresponding purchases. Thermo Fisher Scientific is currently considered fairly valued, trading at $541.2 against a GuruFocus Value of $573.09. The company boasts a substantial market capitalization exceeding $198 billion, underscoring its significant market presence. While insider selling can sometimes signal a lack of confidence, the quantity of shares sold is relatively small compared to the firm's vast market cap. This suggests a potentially minor market impact, or it could be attributed to personal financial considerations for the executive.
Sign in to access this content
Sign In